Erratum: Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (Antimicrobrial Agents and Chemotherapy (2001) 45:11 (3122-3127))

Erratum: Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (Antimicrobrial Agents and Chemotherapy (2001) 45:11 (3122-3127))

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Imwong, M, Pukrittayakamee, S, Looareesuwan, S, Pasvol, G, Poirriez, J, White, N, Snounou, G
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2002

Παρόμοια τεκμήρια

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (vol 45, pg 3122, 2001)
ανά: Imwong, M, κ.ά.
Έκδοση: (2002)

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
ανά: Imwong, M, κ.ά.
Έκδοση: (2001)

Plasmodium vivax: polymerase chain reaction amplification artifacts limit the suitability of pvgam1 as a genetic marker.
ανά: Imwong, M, κ.ά.
Έκδοση: (2001)

Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
ανά: Peto, T, κ.ά.
Έκδοση: (1985)

Sulfadoxine-pyrimethamine for the treatment of malaria.
ανά: White, N
Έκδοση: (1991)

High levels of Sulfadoxine-Pyrimethamine resistance dhfr-dhps quintuple mutations: a cross sectional survey of six regions in Tanzania
ανά: S.I. Matondo, κ.ά.
Έκδοση: (2014-04-01)

<it>Plasmodium vivax dhfr </it>and <it>dhps </it>mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine
ανά: Jahevitra Martial, κ.ά.
Έκδοση: (2008-02-01)

Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
ανά: Divya Goel, κ.ά.
Έκδοση: (2016-01-01)

Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.
ανά: Hastings, MD, κ.ά.
Έκδοση: (2004)

Comparative efficacy of chloroquine and pyrimethamine-sulfadoxine versus artemether and pyrimethamine-sulfadoxine in the treatment of uncomplicated falciparum malaria in children
ανά: Femmy Tambajong, κ.ά.
Έκδοση: (2016-10-01)

Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax.
ανά: Imwong, M, κ.ά.
Έκδοση: (2011)

Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
ανά: Sofonias K Tessema, κ.ά.
Έκδοση: (2015-01-01)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
ανά: Ratcliff, A, κ.ά.
Έκδοση: (2007)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
ανά: Basco Leonardo K., κ.ά.
Έκδοση: (2002-01-01)

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
ανά: Barnes, K, κ.ά.
Έκδοση: (2006)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
ανά: Thiery Masserey, κ.ά.

Assessment of the Teratogenic Effect of Sulfadoxine-Pyrimethamine on the Chicken Embryo
ανά: Rachida Moussa Tari, κ.ά.
Έκδοση: (2022-01-01)

Prevention of malaria in pregnancy: The threat of sulfadoxine-pyrimethamine resistance
ανά: Sesh A. Sundararaman, κ.ά.
Έκδοση: (2022-08-01)

Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.
ανά: Imwong, M, κ.ά.
Έκδοση: (2005)

Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
ανά: Awab, GR, κ.ά.
Έκδοση: (2016)

Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
ανά: Imwong, M, κ.ά.
Έκδοση: (2005)

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
ανά: Pukrittayakamee, S, κ.ά.
Έκδοση: (2004)

Resistência à sulfadoxina-pirimetamina em Maputo, Moçambique: presença de mutações nos genes dhfr e dhps do Plasmodium falciparum Sulfadoxine-pyrimethamine resistance in Maputo, Mozambique: presence of mutations in the dhfr and dhps genes of Plasmodium falciparum
ανά: Natércia Emília Pedro Fernandes, κ.ά.
Έκδοση: (2007-08-01)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
ανά: Philippe Deloron, κ.ά.
Έκδοση: (2010-11-01)

Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas
ανά: Larissa Rodrigues Gomes, κ.ά.
Έκδοση: (2019-02-01)

Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.
ανά: Nosten, F, κ.ά.
Έκδοση: (1987)

Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.
ανά: Imwong, M, κ.ά.
Έκδοση: (2003)

Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: A counter perspective
ανά: Nosten, F, κ.ά.
Έκδοση: (2015)

Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'.
ανά: Harrington, W, κ.ά.
Έκδοση: (2012)

Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: the times they are a-changin'
ανά: Harrington, W, κ.ά.
Έκδοση: (2014)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
ανά: Alexandra T. Roux, κ.ά.
Έκδοση: (2021-06-01)

Ab initio study of opto electric properties of the molecules pyrimethamine and sulfadoxine
ανά: S. Nouemo, κ.ά.
Έκδοση: (2015-10-01)

<it>In vitro </it>susceptibility to pyrimethamine of DHFR I164L single mutant <it>Plasmodium falciparum</it>
ανά: Bouchier Christiane, κ.ά.
Έκδοση: (2011-09-01)

Practical PCR genotyping protocols for <it>Plasmodium vivax </it>using <it>Pvcs </it>and <it>Pvmsp1</it>
ανά: Looareesuwan Sornchai, κ.ά.
Έκδοση: (2005-04-01)

Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine in Pregnancy: Low Coverage and High Prevalence of <i>Plasmodium falciparum</i> dhfr-dhps Quintuple Mutants as Major Challenges in Douala, an Urban Setting in Cameroon
ανά: Carole Else Eboumbou Moukoko, κ.ά.
Έκδοση: (2023-06-01)

Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
ανά: Hastings, MD, κ.ά.
Έκδοση: (2005)

The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya.
ανά: Zurovac, D, κ.ά.
Έκδοση: (2005)

Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar.
ανά: Smithuis, F, κ.ά.
Έκδοση: (1997)

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
ανά: Nimita Deora, κ.ά.
Έκδοση: (2024-07-01)

The Comparative Effects of Antenatal Azithromycin and Sulfadoxine-pyrimethamine on Maternal Malaria during Pregnancy
ανά: Ganiyu Olanipekun Ahmed, κ.ά.
Έκδοση: (2024-10-01)